Pune, India, July 27, 2021 (GLOBE NEWSWIRE) -- The global ambulatory arrhythmia monitoring devices market size is projected to expand steadily owing to rising prevalence of cardiac arrhythmia, shares Fortune Business Insights™ in its report, titled “Ambulatory Arrhythmia Monitoring Devices Market Size, Share & Industry Analysis, By Device Type (Resting ECG, Event Monitor, Implantable Cardiac Monitor, Holter Monitor, Mobile Cardiac Telemetry Devices, Others), By Application (Tachycardia, Bradycardia, Atrial Fibrillation), By End-User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers)and Regional Forecast, 2019-2026”. According to the International Journal of Stroke, 3.046 million new cases of atrial fibrillation, the most common form of cardiac arrhythmia, were registered in the Global Health Data Exchange database in 2017.
Moreover, studies published in the journal predict that this condition will affect roughly 9 million people in the US by 2050 and approximately 18 million people in Europe by 2060. Ambulatory arrhythmia monitoring devices enable doctors and emergency medical responders to keep track of a patient’s heartbeat patterns outside the hospital or any outpatient setting. Since these devices allow remote and prolonged monitoring of unusual heart behaviour in a patient, their adoption is expected to rise as cardiac complications become more widespread.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ambulatory-arrhythmia-monitoring-devices-market-102507
The COVID-19 pandemic has crunched economic activities, affecting industries and businesses around the world. Lockdowns and social distancing have fanned fears about an imminent economic recession, and have disrupted supply chain networks, pushing down demand for goods and services globally. Governments are taking several efforts to mitigate the damage caused by this pandemic, but uncertainty continues to be prevalent. However, collective strength and unity will help us tide over these hard times. At Fortune Business Insights, we are constantly striving to develop comprehensive research reports on various markets so as to equip your business with the necessary intelligence to emerge victorious on the other side of this crisis.
Highlights of the Report:
- Valuable analysis of the market drivers, trends, and restraints;
- Comprehensive assessment of the various segments of the market;
- Actionable research into the regional opportunities impacting the market; and
- In-depth study of the major market players and their dominant strategies.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/ambulatory-arrhythmia-monitoring-devices-market-102507
Industry Developments:
- June 2019: ZOLL Medical Corporation released its Heart Failure and Arrhythmia Management System (HFAMS) called the ZOLL Micro Cure or “ZOLL µCor™”. The system is aimed at improving clinical outcomes for patients by bringing down hospitalization frequency for patients with problems of fluid management.
- May 2019: Abbott introduced the Confirm Rx™ insertable cardiac monitor (ICM), an innovative smart monitor for tracking heart behavior in patients suffering from arrhythmia. The product, which is a paperclip-sized implantable device that can be synced with a smartphone, has received clearance from the US Food and Drug Administration (FDA) and has received the CE Mark in Europe.
Launch of Smart Monitoring Solutions by Top Players to Intensify Market Competition
Competition dynamics in this market are determined by the actions of a few key players, whose strategies are augmenting the ambulatory arrhythmia monitoring devices market growth. These players are focused on developing and launching monitoring solutions embedded with smart technologies to make heart monitoring more efficient and accurate.
Market Driver
Increasing Prevalence of Diabetes Globally to Feed Market Growth
The International Diabetes Foundation (IDF) estimates that over 460 million adults worldwide were living with diabetes in 2019 and this number is expected to rise to 700 million by 2045. Furthermore, the IDF observes that the incidence of type 2 diabetes is rising in majority of the countries. Type 2 Diabetes is known to heighten the risk of atrial fibrillation by 40%, according to a research study published in the Journal of General Internal Medicine in 2010.
Glucose and insulin imbalance caused by Diabetes Mellitus can directly impact the myocardium in the atrium and ventricle, giving rise to atrial fibrillation. Many other epidemiological studies have found strong correlation between diabetes and heart arrhythmia and therefore, increasing prevalence of diabetes is likely to boost the adoption of ambulatory arrhythmia monitoring devices in the coming years.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/customization/ambulatory-arrhythmia-monitoring-devices-market-102507
North America to Secure Leading Market Position; Europe to Follow Closely
Geographically, North America is expected to have a commanding hold on the ambulatory arrhythmia monitoring devices market share in the forthcoming years. This is mainly attributable to various epidemiological forecasts that reveal that the incidence of atrial fibrillation is slated to increase considerably in the next few decades. In Europe, on the other hand, the main market drivers will be robust healthcare infrastructure, growing geriatric population, and rapid adoption of advanced health technologies. The market in Asia Pacific is also expected to exhibit healthy growth owing to rising number of cardiac patients in the region.
List of Companies Profiled in the Ambulatory Arrhythmia Monitoring Devices Market Report:
- GENERAL ELECTRIC COMPANY
- ZOLL Medical Corporation
- Abbott
- Biotronik, Inc.
- MediLynx
- Medtronic
- BioTelemetry, Inc.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/queries/ambulatory-arrhythmia-monitoring-devices-market-102507
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs